Gilde Healthcare

Portfolio Co Investors 2026 for Gilde Healthcare: investors, rounds, and co-investor patterns from StartupFundraising.com research, updated for 2026.

Gilde Healthcare accounts for 22 tracked companies with verified cap-table data, 22 of which disclose round sizes totalling $2.7B. The median disclosed raise is $94M, and the largest is Karius at $355M, ahead of CVRx ($340M) and GT Medical Technologies ($182M).

The names that recur most often on these co-invested cap tables are Gilde Healthcare (22 companies), Ysios Capital (6 companies), Forbion (5 companies), New Enterprise Associates (4 companies), Novartis Venture Fund (4 companies), Vensana Capital (3 companies). By latest disclosed round, the market skews Series B (7), Series C (4), Series A (4), Series D (3).

Best funded Gilde Healthcare companies

  1. Karius — $355M (latest: Series C)
  2. CVRx — $340M
  3. GT Medical Technologies — $182M (latest: Series E)
  4. AM Pharma — $176M (latest: Series C)
  5. Splice Bio — $170M (latest: Series B)
  6. Alleviant Medical — $167M (latest: Series B)
  7. Mainstay Medical — $125M (latest: Growth)
  8. ProVerum Medical — $114M (latest: Series B)
  9. Sidera Bio — $109M (latest: Series A)
  10. Purespring Therapeutics — $105M (latest: Series B)
  11. Withings — $94M (latest: Series B)
  12. LUMICKS — $93M (latest: Series D)
  13. SynOx Therapeutics — $92M (latest: Series B)
  14. Ablative Solutions — $91M (latest: Series D)
  15. Lava Therapeutics — $83M (latest: Series C)

Gilde Healthcare — related firms and companies (56)

Gilde Healthcare profile · All research reports